Literature DB >> 8996412

Is death inevitable with multiresistant TB plus HIV infection?

F Drobniewski1.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 8996412     DOI： 10.1016/S0140-6736(05)60878-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  Differentiation of Mycobacterium tuberculosis complex and nontuberculous mycobacterial liquid cultures by using peptide nucleic acid-fluorescence In situ hybridization probes.

Authors:  F A Drobniewski; P G More; G S Harris
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Diagnosing multidrug resistant tuberculosis in Britain. Clinical suspicion should drive rapid diagnosis.

Authors:  F A Drobniewski
Journal:  BMJ       Date:  1998-11-07

Review 3.  Prion diseases: what will be next?

Authors:  P van der Valk
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

Review 4.  New agents for the treatment of drug-resistant Mycobacterium tuberculosis.

Authors:  Daniel T Hoagland; Jiuyu Liu; Robin B Lee; Richard E Lee
Journal:  Adv Drug Deliv Rev       Date:  2016-05-02       Impact factor: 15.470

5.  Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide, and ciprofloxacin among clinical isolates of Mycobacterium tuberculosis.

Authors:  I J Eltringham; S M Wilson; F A Drobniewski
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  Induction of zidovudine glucuronidation and amination pathways by rifampicin in HIV-infected patients.

Authors:  K D Gallicano; J Sahai; V K Shukla; I Seguin; A Pakuts; D Kwok; B C Foster; D W Cameron
Journal:  Br J Clin Pharmacol       Date:  1999-08       Impact factor: 4.335

7.  Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

8.  A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK.

Authors:  F Drobniewski; I Eltringham; C Graham; J G Magee; E G Smith; B Watt
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

9.  Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis.

Authors:  S A Watterson; S M Wilson; M D Yates; F A Drobniewski
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

10.  Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.

Authors:  Prabagaran Narayanasamy; Barbara L Switzer; Bradley E Britigan
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.